TherapeuticsMD, Inc. (29TA)
Munich
1.89
0.00 (0.00%)
Closed
Aug 31, 2026
Day's Range
1.891.89
52 wk Range
0.90002.20
Financial Statements - 29TA - TherapeuticsMD, Inc.
Revenue
3.02M▲ 71.6%
Net Income
-569.00K▲ 73.9%Net Margin -18.8%
EBITDA
-2.84M▼ 65.9%
Free Cash Flow
2.45M▲ 109.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.02M | 1.76M | - | 69.96M | 2.57M | 64.87M |
| Cost of Goods | - | - | - | 1.39M | 1.40M | 15.97M |
| Gross Profit | - | - | - | 68.56M | 1.17M | 48.89M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -4.21M | -3.49M | - | 10.66M | -79.57M | -155.54M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 3.41M | 1.14M | - | -9.58M | 272K | 598K |
| Pre Tax Income | -653K | -2.34M | - | 1.07M | -79.30M | -183.52M |
| Income Tax | 0 | -31K | - | 0 | 0 | 0 |
| Net Income | -569K | -2.18M | - | 111.99M | -172.41M | -183.52M |
| EPS Basic | -0.05 | -0.19 | -0.98 | 12.41 | -21.5 | -33.5 |
| EPS Diluted | -0.05 | -0.19 | -0.98 | 11.96 | -21.5 | -33.5 |
| Basic Shares Outstanding | 11.56M | 11.53M | 11.26M | 9.39M | 8.28M | 5.73M |
| Diluted Shares Outstanding | 11.56M | 11.53M | 11.26M | 9.39M | 8.28M | 5.73M |
| Ebit | -4.21M | -3.49M | - | 10.66M | -79.57M | -157.47M |
| Ebitda | -2.84M | -1.71M | - | 21.33M | -78.84M | -153.40M |
| Net Income Continuous Operations | -653K | -2.31M | - | 1.07M | -79.30M | -183.52M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
